Picosulfate

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

Information8-OH-DPAT (8-Hydroxy-DPAT) is a kind of classic5-HT1Aagonist with the pIC50 of 8.19. It has a selectivity of almost-1000 fold for a subtype of the 5-HT1 binding site: Its biological half-life is 1.5 hous.Targets5-HT1A (Cell-free)

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,

InformationBaloxavir marboxil Baloxavir marboxil, a cap-endonuclease inhibitor, is an antiviral drug.In vivoSingle-dose oral baloxavir marboxil is well tolerated, had a favorable safety profile, and has favorable pharmacokinetic characteristics,